MeiraGTx Holdings plc (MGTX): Depreciation & Amortization
$12.54M
Year ended 2025-12-31
$12.10M
Trailing 12 months to 2026-06-30
+12.9%
3-year compound annual growth
+24.6%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.54M | -2.2% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $12.83M | -6.6% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $13.73M | +57.4% | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | $8.72M | +10.8% | 2024-03-15, From 2022-01-01 |
| 2021-12-31 | $7.87M | +88.7% | 2023-03-14, From 2021-01-01 |
| 2020-12-31 | $4.17M | +86.4% | 2022-03-10, From 2020-01-01 |
| 2019-12-31 | $2.24M | n/a | 2021-03-11, From 2019-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| MeiraGTx Holdings plc (MGTX) | 2025-12-31 | $12.54M | -2.2% |
| 4D Molecular Therapeutics, Inc. (FDMT) | 2025-12-31 | $4.69M | +0.9% |
| Autolus Therapeutics plc (AUTL) | 2025-12-31 | $8.30M | +9.8% |
| Recursion Pharmaceuticals, Inc. (RXRX) | 2025-12-31 | $83.70M | +129.4% |
| Vir Biotechnology, Inc. (VIR) | 2025-12-31 | $11.68M | -19.8% |
| Sutro Biopharma, Inc. (STRO) | 2025-12-31 | $7.32M | +1.5% |
| Champions Oncology, Inc. (CSBR) | 2026-04-30 | $1.38M | -16.0% |
| ImmunityBio, Inc. (IBRX) | 2025-12-31 | $15.53M | -11.6% |
| Agenus Inc (AGEN) | 2025-12-31 | $10.00M | -25.1% |
Compare MGTX, FDMT, AUTL, RXRX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗